Oncimmune Holdings (ONC)

19.70p
   
  • Change Today:
    -4.80p
  • 52 Week High: 29.10
  • 52 Week Low: 15.10
  • Currency: UK Pounds
  • Shares Issued: 74.14m
  • Volume: 147,940
  • Market Cap: £14.61m

Latest ShareCast News

Oncimmune revenue falls as it implements new strategy

By Josh White

Date: Thursday 29 Feb 2024

(Sharecast News) - Oncimmune reported revenue of £2.1m in its final results on Thursday, down from £3.8m for the prior extended 15-month period, with revenue from continuing operations totalling £1.2m.

Oncimmune sells 'non-core' lung and antibody assets in £13m deal

By Josh White

Date: Monday 22 May 2023

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced the sale of its wholly-owned subsidiaries Oncimmune Limited and Oncimmune Europe to the US-based, privately-held Freenome Holdings on Monday.

Oncimmune enters collaboration with Siemens Healthineers

By Josh White

Date: Friday 17 Feb 2023

(Sharecast News) - Immunodiagnostics specialist Oncimmune announced a collaboration with Siemens Healthineers on Friday, to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs).

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ONC Market Data

Currency UK Pounds
Share Price 19.70p
Change Today -4.80p
% Change -19.59 %
52 Week High 29.10
52 Week Low 15.10
Volume 147,940
Shares Issued 74.14m
Market Cap £14.61m

ONC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

ONC Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
16:27 11,883 @ 19.24p
14:47 9,187 @ 19.26p
14:44 6,751 @ 20.13p
14:41 10,000 @ 20.80p
14:41 2,158 @ 20.96p

ONC Key Personnel

CEO Martin Gouldstone

Top of Page